These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 6075279)
21. [The new drug law of the German Democratic Republic and its significance for the evaluation of drugs]. Richter J Z Arztl Fortbild (Jena); 1965 Apr; 59(8):413-20. PubMed ID: 5887305 [No Abstract] [Full Text] [Related]
22. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. Xu EY; Schaefer WH; Xu Q Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212 [TBL] [Abstract][Full Text] [Related]
23. Researchers and subpoenas: the troubling precedent of the Selikoff case. Holder AR IRB; 1989; 11(6):8-10. PubMed ID: 11650287 [No Abstract] [Full Text] [Related]
24. Sociology of pharmaceuticals development and regulation: a realist empirical research programme. Abraham J Sociol Health Illn; 2008 Sep; 30(6):869-85. PubMed ID: 18761508 [TBL] [Abstract][Full Text] [Related]
25. International research agreement leads to new U.S. guidelines. Maloney DM Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182 [No Abstract] [Full Text] [Related]
26. A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development. Robinson S; Delongeas JL; Donald E; Dreher D; Festag M; Kervyn S; Lampo A; Nahas K; Nogues V; Ockert D; Quinn K; Old S; Pickersgill N; Somers K; Stark C; Stei P; Waterson L; Chapman K Regul Toxicol Pharmacol; 2008 Apr; 50(3):345-52. PubMed ID: 18295384 [TBL] [Abstract][Full Text] [Related]
27. [Research of for the discovery of new drugs and research for the development and production of drugs]. Setnikar I Boll Chim Farm; 1971 Sep; 110(9):503-9. PubMed ID: 5137987 [No Abstract] [Full Text] [Related]
28. New horizons in drug metabolism, pharmacokinetics and drug discovery. Palmer AM Drug News Perspect; 2003; 16(1):57-62. PubMed ID: 12682673 [TBL] [Abstract][Full Text] [Related]
29. [Uses and limits of radiotracers in the study of drugs and xenobiotics metabolism (author's transl)]. Cohen Y Ann Pharm Fr; 1980; 38(3):279-94. PubMed ID: 6999962 [No Abstract] [Full Text] [Related]
30. [Species differences in pharmaco-kinetics of chemicals. Correlations with toxicity (author's transl)]. Keck G Toxicol Eur Res; 1981 Jul; 3(4):207-15. PubMed ID: 7302948 [TBL] [Abstract][Full Text] [Related]
31. Current and future trends in the application of HPLC-MS to metabolite-identification studies. Castro-Perez JM Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890 [TBL] [Abstract][Full Text] [Related]
32. Resurrection men dig through the drug graveyard: ARYx revives problem blockbuster drugs. Wolfson W Chem Biol; 2005 Nov; 12(11):1155-6. PubMed ID: 16298292 [No Abstract] [Full Text] [Related]
33. [The importance of glucose repression to the industrial production of biogenic drugs: studies with Penicillium cyclopium as a model (proceedings)]. Schröder P Pharmazie; 1979; 34(5-6):358-9. PubMed ID: 515156 [No Abstract] [Full Text] [Related]
34. Safety assessment of drug metabolites: Characterization of chemically stable metabolites. Humphreys WG; Unger SE Chem Res Toxicol; 2006 Dec; 19(12):1564-9. PubMed ID: 17173369 [TBL] [Abstract][Full Text] [Related]
35. [Increased significance of adverse effects of drugs--a threat to the industry]. Werkö L Lakartidningen; 2004 Dec; 101(50):4134-6. PubMed ID: 15631270 [No Abstract] [Full Text] [Related]
39. Drugs in pregnancy: acknowledging challenges--finding solutions. Koren G; MacLeod S; Davis D Can J Clin Pharmacol; 2007; 14(1):e2-4. PubMed ID: 17213506 [No Abstract] [Full Text] [Related]
40. A basic approach to the development of drugs. Ariëns EJ Ann Ist Super Sanita; 1967; 3(3):412-42. PubMed ID: 5618700 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]